[18F]AlF-ND-bisFAPI PET imaging of fibroblast activation protein as a biomarker to monitor the progression of liver fibrosis.
Hongsheng LiRuoxue DaiYueqi HuangJiawei ZhongQingsong YanJiaqi YangKongzhen HuYuhua ZhongPublished in: Hepatology communications (2024)
[18F]AlF-ND-bisFAPI positron emission tomography imaging is a promising noninvasive method for monitoring the progression of liver fibrosis.